Poolbeg Pharma PLC Announces TR-1: Notification of Major Holdings

LONDON, UK / ACCESSWIRE / April 29, 2024 / TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:			Poolbeg Pharma PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer 2. Reason for the notification (please mark the appropriate box or boxes with an "X") An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments An event changing the breakdown of voting rights Other (please specify)ⁱⁱⁱ: 3. Details of person subject to the notification obligation^iv Name Michael Kelly City and country of registered office (if applicable) 4. Full name of shareholder(s) (if different from 3.)^v Name City and country of registered office (if applicable) 5. Date on which the threshold was crossed or reached^vi: 15^TH March 2024 6. Date on which issuer notified (DD/MM/YYYY): 26^th April 2024 7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer^vii Resulting situation on the date on which threshold was crossed or reached

4.8%

4.8%

23,988,955

Position of previous notification (if

applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)	Number of voting rightsix		% of voting rights
	Direct (DTR5.1)	Indirect (DTR5.2.1)	Direct (DTR5.1)	Indirect (DTR5.2.1)
GB00BKPG7Z60		23,988,955		4.8%
SUBTOTAL 8. A	23,988,955		4.8%

B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument	Expiration datex	Exercise/ Conversion Periodxi	Number of voting rights that may be acquired if the instrument is exercised/converted.	% of voting rights
		SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument	Expiration datex	Exercise/ Conversion Period xi	Physical or cash settlementxii	Number of voting rights	% of voting rights
			SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)				X
Namexv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Michael Kelly
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional informationxvi

Place of completion	Dublin, Ireland
Date of completion	26th April 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

SOURCE: Poolbeg Pharma PLC

View the original press release on accesswire.com


The Poolbeg Pharma Stock at the time of publication of the news with a raise of +1,72 % to 0,118GBP on London stock exchange (26. April 2024, 18:40 Uhr).